NHS England has appealed for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) which can lead to serious complications in some. It is sending ...

NHS England announced on Monday that more than one million adults in England, aged between 75 and 79, or those who turned 80 after September 1, will be invited to receive the RSV jab over the next ...

With this in mind, health officials are urging older adults to get vaccinated against respiratory syncytial virus (RSV), which causes infections of the lungs and respiratory tract. The NHS states ...

More than one million Brits are being urged to get a potentially "life-saving" new jab against respiratory syncytial virus (RSV). NHS officials have urgently invited elderly people in England to ...

More than one million people in England have been urged to get vaccines for respiratory syncytial virus (RSV), with health officials warning that the virus is ‘not just a winter illness’.

Invites are being sent this week to people not yet vaccinated against RSV who are aged 75-79 or turned 80 after 1 September 2024, encouraging them to book an appointment with their GP. RSV spreads all ...

The patents in contention are numbers 3,109,258, 2,222,710 and 3,178,490, all awarded by the European Patent Office and covering recombinant RSV antigens and compositions and methods for making them.

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...